Why Invest in the Healthcare Sector?
- Healthcare is no longer just about hospitals or medicines. It’s now a fast-growing ecosystem that includes diagnostics, wellness and nutrition, biotechnology, analytics, medical equipment, health-tech, and more, all scaling up to meet rising demand.
- India’s ageing population and rising income levels are driving steady, long-term demand.
- The sector has grown at a 16% CAGR (2008–2023) to reach USD 372 billion, yet per-capita spending remains low, leaving ample room for potential future growth.
- For investors, that makes healthcare a strong structural growth opportunity.
#1 Balanced Portfolio Across Four Healthcare Themes
Diversified exposure with core allocation (20–30% each) across Hospitals & Diagnostics, Export CDMO/API, Export Generics, and Domestic Branded Formulations##.
#2 Bottom-Up Precision
Segment-specific research across the four focus themes, assessing therapy growth, capacity expansion, innovation pipelines, pricing environment, regulatory track record, and brand strength to identify high-quality opportunities.
API: Active Pharmaceutical Ingredient
#3 Disciplined Stock Selection
A research-driven approach guided by valuation comfort, ROCE, management quality, and sustainable growth potential.
Looking to learn more about the fund?
Watch our explainer videos in your preferred language.
Consider investing in this fund if…
Downloads
Make an informed decision. Learn more about investing in Bandhan Healthcare Fund
Fund Facts
Type of Scheme
An open-ended equity scheme investing in healthcare, pharma and allied services
NFO Period
10th November to 24th November 2025
Benchmark
BSE Healthcare TRI
Fund Managers
Mr. Viraj Kulkarni & Mr. Brijesh Shah
Minimum Investment
During New Fund Offer
₹ 1,000
And in multiples of Re. 1 thereafter
Exit Load
If redeemed / switched out on / within 30 days from the date of allotment: 0.50% of the applicable NAV
If redeemed / switched out after 30 days from date of allotment – Nil
Plans/Options
Regular/Direct Plan: Growth Option
Investment Objective
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors.
Disclaimer: There is no assurance or guarantee that the scheme’s objectives will be realized.
Fund Managers
Mr. Viraj Kulkarni
Vice President – EquitiesBandhan AMC Limited
September 2015 to date
Mr. Viraj Kulkarni serves as a Senior Analyst and Fund Manager in the Equity
Fund management team at Bandhan AMC. With a focus on sectors such as IT
Services, Cement, and Building materials, he brings nearly a decade of sector-
specific expertise and insights.
Prior to joining Bandhan AMC, Mr. Kulkarni was associated with Franklin
Templeton from May 2014 to September 2015 and had a tenure at Goldman
Sachs from 2010 to 2012.
His educational credentials include a Post Graduate Diploma in Management
(PGDM), a Chartered Financial Analyst (CFA) certification, and a B. Tech degree
in Electrical & Electronics.
Mr. Brijesh Shah
Senior Vice President – Fixed IncomeBandhan AMC Limited
August 2015 to date
Mr. Brijesh Shah currently holds the position of Senior Vice President – Fixed
Income at Bandhan AMC. With a career spanning over 15 years in the fixed-
income arena, Mr. Shah has accumulated extensive experience and expertise in
this field.
Before his tenure at Bandhan AMC, he served at IDBI and Indiabulls AMC. In
these roles, as a Senior Manager, he led the dealing function and was
responsible for the execution of a variety of fixed-income instruments.
Mr. Shah is a postgraduate in Finance from the MET Institute of Management,
Mumbai, and holds a Bachelor's Degree in Commerce from Mithibai College of
Commerce and Economics.
Apart from his professional accomplishments, Mr. Shah is a founding member of
Shasan-Setu, an organization dedicated to societal service. Beyond work, he
nurtures a passion for the arts and has participated in cultural plays and short
films.
Product info
Bandhan Healthcare Fund
(An open-ended equity scheme investing in healthcare, pharma and allied services)
This product is suitable for investors who are seeking*:
- To create wealth over a long term.
- Investment predominantly in equity and equity related instruments of pharma, healthcare and allied companies.
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.